Literature DB >> 8141569

Antimicrobial susceptibility of Arcanobacterium haemolyticum.

P Carlson1, S Kontiainen, O V Renkonen.   

Abstract

The susceptibilities of 138 clinical isolates of Arcanobacterium haemolyticum to 11 antimicrobial agents were tested. All strains were susceptible to phenoxymethylpenicillin, cephalosporins, erythromycin, azithromycin, clindamycin, vancomycin, doxycycline, and ciprofloxacin but were resistant to trimethoprim-sulfamethoxazole.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8141569      PMCID： PMC284411          DOI： 10.1128/AAC.38.1.142

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Vancomycin resistance in south London.

Authors:  G French; Y Abdulla; R Heathcock; S Poston; J Cameron
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

Review 2.  Arcanobacterium haemolyticum: biology of the organism and diseases in man.

Authors:  D C Waagner
Journal:  Pediatr Infect Dis J       Date:  1991-12       Impact factor: 2.129

3.  Penicillin tolerance in Arcanobacterium haemolyticum.

Authors:  M Nyman; G Banck; M Thore
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

4.  Tonsillitis and rash associated with Corynebacterium haemolyticum.

Authors:  G Banck; M Nyman
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

5.  Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov.

Authors:  M D Collins; D Jones; G M Schofield
Journal:  J Gen Microbiol       Date:  1982-06

6.  Comparative studies on Actinomyces pyogenes and Arcanobacterium haemolyticum.

Authors:  C Lämmler; H Blobel
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402
  6 in total
  8 in total

1.  Infective endocarditis caused by Arcanobacterium haemolyticum: a case report.

Authors:  Vanessa Wong; Tom Turmezei; Maria Cartmill; Shiu Soo
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-05-12       Impact factor: 3.944

2.  Identification of Arcanobacterium haemolyticum isolated from postcastrational complications of a horse.

Authors:  M Hijazin; H Ulbegi-Mohyla; J Alber; C Lämmler; A A Hassan; E Prenger-Berninghoff; R Weiss; M Zschöck
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Endocarditis caused by Arcanobacterium haemolyticum.

Authors:  J I Alós; C Barros; J L Gómez-Garcés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

5.  Phenotypic and genotypic characterization of Arcanobacterium haemolyticum isolates from infections of horses.

Authors:  Abdulwahed Ahmed Hassan; Hivda Ulbegi-Mohyla; Talah Kanbar; Jörg Alber; Christoph Lämmler; Amir Abdulmawjood; Michael Zschöck; Reinhard Weiss
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

6.  [Fatal sepsis due to an emerging bacteria: Arcanobacterium hemolyticum].

Authors:  Mohammed Frikh; Abdelhay Lemouer; Mustapha Moutawakil; Adil Maleb; Mostafa Elouennass
Journal:  Pan Afr Med J       Date:  2016-09-27

Review 7.  Clinically Infrequent Arcanobacterium haemolyticum Bacteremia Complicated by Foot Decubitus Ulcer: An Educational Reminder for Primary Care Physicians.

Authors:  Noriko Takamura; Katsushige Tada; Haruhiko Ishioka; Harumi Gomi
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

Review 8.  Systemic and deep-seated infections caused by Arcanobacterium haemolyticum.

Authors:  R L Skov; A K Sanden; V H Danchell; K Robertsen; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.